Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis

gan Johnson, Daniel E.
Cyhoeddwyd 2007

Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit

gan Johnson, Daniel E.
Cyhoeddwyd 2012

The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors

gan Johnson, Daniel E.
Cyhoeddwyd 2014

Bortezomib Induces Autophagy in Head and Neck Squamous Cell Carcinoma Cells via JNK Activation

gan Li, Changyou, Johnson, Daniel E.
Cyhoeddwyd 2011

Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest

gan Li, Changyou, Johnson, Daniel E.
Cyhoeddwyd 2013

An ATRActive future for differentiation therapy in AML

gan Johnson, Daniel E., Redner, Robert L.
Cyhoeddwyd yn Blood Rev (2015)

Signaling by cell surface death receptors: alterations in head and neck cancer

gan Leonard, Brandon C., Johnson, Daniel E.
Cyhoeddwyd yn Adv Biol Regul (2017)

When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials

gan Johnson, Daniel E., Bauman, Julie E.
Cyhoeddwyd yn Cancer Prev Res (Phila) (2017)

Carfilzomib and oprozomib synergize with histone deacetylase inhibitors in head and neck squamous cell carcinoma models of acquired resistance to proteasome inhibitors

gan Zang, Yan, Kirk, Christopher J, Johnson, Daniel E
Cyhoeddwyd 2014

New Therapies in Head and Neck Cancer

gan Santuray, Rodell T., Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Trends Cancer (2018)

Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer

gan Cho, Janice, Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Semin Radiat Oncol (2018)

Targeting the JAK/STAT pathway in solid tumors

gan Qureshy, Zoya, Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn J Cancer Metastasis Treat (2020)

A sensible approach to targeting STAT3-mediated transcription

gan Bhola, Neil E., Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Ann Transl Med (2016)

EGFR-Targeted Therapies in the Post-Genomic Era

gan Xu, Mary Jue, Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Cancer Metastasis Rev (2017)

An update: emerging drugs to treat squamous cell carcinomas of the head and neck

gan Lee, Yoon Se, Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Expert Opin Emerg Drugs (2018)

Investigational multitargeted kinase inhibitors in development for head and neck neoplasms.

gan Sola, Ana Marija, Johnson, Daniel E., Grandis, Jennifer R.
Cyhoeddwyd yn Expert Opin Investig Drugs (2019)

Targeting STAT3 with proteolysis targeting chimeras (PROTACs) and next generation antisense oligonucleotides

gan Shiah, Jamie V., Grandis, Jennifer R., Johnson, Daniel E.
Cyhoeddwyd yn Mol Cancer Ther (2020)

Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells

gan Li, Changyou, Li, Rongxiu, Grandis, Jennifer R., Johnson, Daniel E.
Cyhoeddwyd 2008

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

gan Johnson, Daniel E., O’Keefe, Rachel A., Grandis, Jennifer R.
Cyhoeddwyd yn Nat Rev Clin Oncol (2018)

NSAID Therapy for PIK3CA-Altered Colorectal, Breast, and Head and Neck Cancer

gan Cai, Yi, Yousef, Andrew, Grandis, Jennifer R., Johnson, Daniel E.
Cyhoeddwyd yn Adv Biol Regul (2019)